2.94
price up icon7.92%   0.2157
pre-market  プレマーケット:  3.00   0.06   +2.04%
loading
前日終値:
$2.7243
開ける:
$2.82
24時間の取引高:
23,751
Relative Volume:
0.51
時価総額:
$76.69M
収益:
$6.21M
当期純損益:
$-19.92M
株価収益率:
-2.80
EPS:
-1.05
ネットキャッシュフロー:
$-16.76M
1週間 パフォーマンス:
+10.11%
1か月 パフォーマンス:
-2.00%
6か月 パフォーマンス:
+24.58%
1年 パフォーマンス:
-5.16%
1日の値動き範囲:
Value
$2.80
$2.9728
1週間の範囲:
Value
$2.5001
$2.9728
52週間の値動き範囲:
Value
$1.81
$3.42

InspireMD Inc. Stock (NSPR) Company Profile

Name
名前
InspireMD Inc.
Name
セクター
Healthcare (1176)
Name
電話
972 3 6917691
Name
住所
4 Menorat Hamaor Street, Tel Aviv
Name
職員
36
Name
Twitter
@InspireMD
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
NSPR's Discussions on Twitter

NSPR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
NSPR
InspireMD Inc.
2.94 76.69M 6.21M -19.92M -16.76M -1.05
Medical Devices icon
ABT
Abbott Laboratories
116.79 201.01B 41.22B 5.77B 6.49B 3.29
Medical Devices icon
SYK
Stryker Corp
395.85 150.90B 21.97B 3.59B 3.21B 9.33
Medical Devices icon
BSX
Boston Scientific Corp
100.91 148.72B 15.91B 1.79B 1.89B 1.21
Medical Devices icon
MDT
Medtronic Plc
88.38 113.33B 33.00B 4.29B 5.50B 3.27
Medical Devices icon
EW
Edwards Lifesciences Corp
69.97 41.27B 6.60B 4.16B 490.10M 6.93

InspireMD Inc. Stock (NSPR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2016-01-07 開始されました Rodman & Renshaw Buy
2015-03-13 ダウングレード Oppenheimer Outperform → Perform
2013-11-26 開始されました Oppenheimer Outperform

InspireMD Inc. (NSPR) 最新ニュース

pulisher
Jan 21, 2025

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jan 21, 2025
pulisher
Jan 21, 2025

Compliance Issues And Stock Developments Hit Nasdaq Companies - Evrim Ağacı

Jan 21, 2025
pulisher
Jan 21, 2025

StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World

Jan 21, 2025
pulisher
Jan 20, 2025

InspireMD : Breakthrough device in clinical trials aims to prevent strokes -January 20, 2025 at 07:59 am EST - Marketscreener.com

Jan 20, 2025
pulisher
Jan 14, 2025

Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation - Yahoo Finance

Jan 14, 2025
pulisher
Jan 13, 2025

InspireMD (NYSE:NSPR) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

InspireMD (NYSE:NSPR) Now Covered by StockNews.com - Defense World

Jan 13, 2025
pulisher
Jan 05, 2025

StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World

Jan 05, 2025
pulisher
Dec 28, 2024

InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World

Dec 28, 2024
pulisher
Dec 20, 2024

InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - MarketBeat

Dec 20, 2024
pulisher
Dec 14, 2024

InspireMD, Inc. CFO Craig Shore to Retire, Company Initiates Search for SuccessorDecember 12, 2024 - Defense World

Dec 14, 2024
pulisher
Dec 12, 2024

NSPRInspireMD, Inc. Latest Stock News & Market Updates - StockTitan

Dec 12, 2024
pulisher
Dec 12, 2024

Medical device company kicks off search for next CFO - The Business Journals

Dec 12, 2024
pulisher
Dec 12, 2024

InspireMD CFO Craig Shore to retire, successor search underway - Investing.com India

Dec 12, 2024
pulisher
Dec 12, 2024

InspireMD CFO Retirement Amid Strategic Transition - TipRanks

Dec 12, 2024
pulisher
Dec 12, 2024

InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025 - GlobeNewswire

Dec 12, 2024
pulisher
Dec 12, 2024

InspireMD CFO to Retire After 15 Years Amid Crucial FDA Approval Timeline for Stroke Prevention Device - StockTitan

Dec 12, 2024
pulisher
Dec 12, 2024

NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study - MSN

Dec 12, 2024
pulisher
Dec 12, 2024

Lake Street Initiates Coverage of InspireMD (NSPR) with Buy Recommendation - MSN

Dec 12, 2024
pulisher
Dec 11, 2024

InspireMD Announces First Patient Enrolled in CGUARDIANS II Pivotal Study - Defense World

Dec 11, 2024
pulisher
Dec 10, 2024

Inspiremd Announces First Patient Enrolled in the Cguardians Ii Pivotal Study of the Cguard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures - Marketscreener.com

Dec 10, 2024
pulisher
Dec 09, 2024

InspireMD Advances CGuard Prime with New Clinical Trial - TipRanks

Dec 09, 2024
pulisher
Dec 09, 2024

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR) - GlobeNewswire

Dec 09, 2024
pulisher
Dec 09, 2024

InspireMD Launches Pivotal CGUARDIANS II Trial for Revolutionary Carotid Stent System - StockTitan

Dec 09, 2024
pulisher
Dec 01, 2024

Head to Head Contrast: Penumbra (NYSE:PEN) vs. InspireMD (NYSE:NSPR) - Defense World

Dec 01, 2024
pulisher
Nov 26, 2024

InspireMD adds medtech veteran Scott Ward to its board By Investing.com - Investing.com South Africa

Nov 26, 2024
pulisher
Nov 26, 2024

InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World

Nov 26, 2024
pulisher
Nov 26, 2024

InspireMD appoints Scott R. Ward to its Board - Medical Buyer

Nov 26, 2024
pulisher
Nov 26, 2024

InspireMD Appoints Scott R. Ward to Board of Directors - Defense World

Nov 26, 2024
pulisher
Nov 25, 2024

InspireMD, Inc. Appoints Scott R. Ward to Its Board of Directors - Marketscreener.com

Nov 25, 2024
pulisher
Nov 25, 2024

InspireMD adds medtech veteran Scott Ward to its board - Investing.com

Nov 25, 2024
pulisher
Nov 25, 2024

InspireMD Strengthens Leadership with Scott R. Ward Appointment - TipRanks

Nov 25, 2024
pulisher
Nov 25, 2024

InspireMD Announces Appointment of Accomplished Medical - GlobeNewswire

Nov 25, 2024
pulisher
Nov 25, 2024

InspireMD Strengthens Board with Ex-Medtronic Executive Ahead of CGuard Prime FDA Decision | NSPR Stock News - StockTitan

Nov 25, 2024
pulisher
Nov 15, 2024

InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023) - Simply Wall St

Nov 15, 2024
pulisher
Nov 14, 2024

InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 14, 2024
pulisher
Nov 14, 2024

InspireMD Inc (NSPR) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 13, 2024

InspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

InspireMD Inc. Faces Financial Uncertainty Amidst Ongoing Losses and Cash Flow Challenges - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

InspireMD Inc. Reports Q3 2024 Financial Results - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

InspireMD Achieves Record Q3 Revenue with CGuard Success - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

InspireMD Sets Revenue Record, Files FDA Approval for CGuard Stent Amid Wider Losses | NSPR Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

What To Expect From InspireMD Inc (NSPR) Q3 2024 Earnings - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

InspireMD announces inducement grants - Medical Buyer

Nov 11, 2024

InspireMD Inc. (NSPR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices STE
$217.07
price up icon 3.55%
medical_devices ZBH
$110.52
price up icon 0.88%
medical_devices PHG
$26.57
price up icon 2.98%
$86.32
price up icon 2.30%
$87.34
price up icon 3.07%
medical_devices EW
$69.97
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):